Sylentis news
1 Alnylam Pharmaceuticals Grants InterfeRx(TM) Intellectual Property License to Sylentis for Development and Commercialization of RNAi Therapeutics 17/11/2011
2 Sylentis, a pioneer in RNAi technology, obtains authorisation as research drug manufacturing laboratory 31/01/2011
3 Sylentis awarded the Madrid Excelente insignia, which recognises and certifies quality and excellence in company management 18/01/2011
4 El Proyecto DENDRIA , en el que participa Sylentis, recibe la aprobación en la sexta convocatoria del Programa de Consorcios Estratégicos Nacionales en Investigación Técnica (CENIT) 04/08/2010
5 Sylentis launches its new corporate image 11/03/2009
6 Sylentis Receives Award to Best Business Plan 25/06/2008

Sylentis © 2010 •  RNAi Company • All rights reserved | contact | legal info | info@sylentis.com